Reports for TEVA-NAPROXEN
Brand name
TEVA-NAPROXEN
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
00589861 |
Ingredients
NAPROXEN |
Ingredient Strength
500 MG |
ATC Code
M01AE |
ATC Descriptor
ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-NAPROXEN | 500 | Resolved | 2020-02-21 | 2020-04-02 | 106916 |
| TEVA-NAPROXEN | 500 | Resolved | 2022-11-14 | 2023-01-19 | 174583 |
| TEVA-NAPROXEN | 100 | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
| TEVA-NAPROXEN | 500 | Resolved | 2023-07-20 | 2023-07-28 | 199306 |
| TEVA-NAPROXEN | 100 | Resolved | 2023-07-27 | 2023-08-18 | 200203 |
| TEVA-NAPROXEN | 100 | Resolved | 2023-11-23 | 2024-01-11 | 211319 |
| TEVA-NAPROXEN | 100 | Actual shortage | 2024-02-01 | 2024-04-22 | 218123 |
| TEVA-NAPROXEN | 500 | Actual shortage | 2024-02-01 | 2024-04-22 | 218126 |
Showing 1 to 8 of 8
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0